Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1994-09-26
1998-09-22
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 691, 435 701, 435 703, 530303, C12N 1517, C12P 2102
Patent
active
058112669
ABSTRACT:
The present disclosure relates to the application of genetic engineering to provide artificial .beta. cells, i.e. cells which can secrete insulin in response to glucose. This is achieved preferably through the introduction of one or more genes selected from the insulin gene, glucokinase gene, and glucose transporter gene, so as to provide an engineered cell having all three of these genes in a biologically functional and responsive configuration. Assays for detecting the presence of diabetes-associated antibodies in biological samples using these and other engineered cells expressing diabetes-associated epitopes are described. Also disclosed are methods for the large-scale production of insulin by perfusing artificial .beta. cells, grown in liquid culture, with glucose-containing buffers.
REFERENCES:
patent: 4195125 (1980-03-01), Wacker
patent: 5073491 (1991-12-01), Fanilletti
patent: 5175085 (1992-12-01), Johnson et al.
patent: 5427940 (1995-06-01), Newgard
Aaen et al., "Dependence of Antigen Expression on Functional State of .beta.-Cells," Diabetes, 39:697-701, 1990.
Andersson et al., "Effects of Glucose on the Ultrastructure and Insulin Biosynthesis of Isolated Mouse Pancreatic Islets Maintained in Tissue Culture," Diabetologia, 10:743-753, 1974.
Arguad et al., "Adenovirus-mediated overexpression of liver 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase in gluconeogenic rat hepatoma cells," J. Biol. Chem., 270:24229-24236, 1995.
Asfari et al., "Establishment of 2-Mercaptoethanol-Dependent Differentiated Insulin-Secreting Cell Lines," Endocrinology, 130(1):167-178, 1992.
Atkinson et al., "Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy," Diabetes, 39:933-937, 1990.
Becker et al., "Use of recombinant adenovirus for metabolic engineering of mammalian cells," Methods in Cell Biology, Roth, M., Ed. New York, Academic Press, 43:161-189, 1994.
Becker et al., "Overexpression of Hexokinase I in Isolated Islets of Langerhans via Recombinant Adenovirus," J. Biol. Chem., 269(33):21234-21238, Aug., 1994.
BeltrandelRio et al., "Molecular on Chemical Reduction in Hexokinase Expression Alters Glucose Dose-Response in Engineered Insulinoma Cells," Diabetes 43, Suppl. 1:91A, 1994.
BeltrandelRio et al., "Genetic engineering of insulin secreting cells lines," In Pancreatic Islet Transplantation vol. 1: Procurement of Pancreatic Islets, Lanza, R.P. and Chick, W.L. Eds., R.G. Landes Co., 15:169-183, 1994.
Blasquez et al., "Trehalose-6-phosphate, a new regulator of yeast glycolysis that inhibits hexokinases," FEBS Lett., 329(1,2):51-54, Aug., 1993.
Cassidy and Newgard, Glucose-stimulated insulin secretion in cell lines, Diab. Nutr. Metab., 7:189-195, 1994.
Chavez et al., "Expression of exogenous proteins in cells with regulated secretory pathways," Methods in Cell Biology, 43 PartA:263-288, 1994.
Chen et al., "Regulated Secretion of Prolactin by the mouse cell line Beta TC-3," Biotechnology, 13:1191-1197, 1995.
Clark et al., "Modulation of Glucose-Induced Insulin Secretion from a Rat Clonal .beta.-Cell Line," Endocrinology, 127(6):2779-2788, 1990.
Courchesne-Smith et al., "Cytoplasmic Accumulation of a Normally Mitochondrial Malonyl-CoA Decarboxylase by the Use of an Alternate Transcription Start Site," Arch. Biochem. and Biophys., 298(2):576-586, Nov., 1992.
Ferber et al., "Heterogeneity of expression and secretion of native and 1991.
Ferber et al., "GLUT-2 Gene Transfer into Insulinoma Cells Confers Both Low and High Affinity Glucose-stimulated Insulin Release," J. Biol. Chem., 269(15):11523-11529, Apr., 1994.
Fiedorek et al., "Selective secreting cell lines established from a transplantable rat islet cell tumor," Mol. Endocrinol., 4(7):990-999, 1990.
Finney et al., "Monoclonal Antibodies Against Rat Brain Hexokinase Effects on Catalytic Function and Binding to the Outer Mitochondrial Membrane," J. Biol. Chem., 259(13):8232-8237, 1984.
Gelb et al., "Targeting of hexokinase 1 to liver the hepatoma mitochondria," Proc. Natl. Acad. Sci. USA, 89:202-206, Jan., 1992.
Grampp et al., "Use of regulated secretion in protein production from animal cells: An overview," Advances in Biochemical Engineering, 46:35-62, 1992.
Gross et al., "Partial diversion of a mutant proinsulin (B10 aspartic acid) from the regulated to the constitutive secretory pathway in transfected AtT-20 cells," Proc. Natl. Acad. Sci. USA, 86:4107-4111, 1989.
Gumbiner and Kelly, "Secretory granules of an anterior pituitary cell line, AtT-20, contain only mature forms of corticotropin and beta-lipotropin," Proc. Natl. Acad. Sci. USA, 78(1):318-322, Jan., 1981.
Jang et al., "Molecular Cloning, Nucleotide Sequence, and Tissue Distribution of Malonyl-CoA Decarboxylase," J. Biol. Chem., 264(6):3500-3505, Feb., 1989.
Kabir and Wilson, "Mitochondrial Hexokinase in Brain of Various Species: Differences in Sensitivity to Solubilization by Glucose 6-Phosphate," Arch. Biochem. Biophys., 300:641-650, 1993.
Kabir and Wilson, "Mitochondrial Hexokinase in Brain: Coexistence of Forms Differing in Sensitivity to Solubilization by Glucose-6-Phosphate on the Same Mitochondria," Arch. Biochem. Biophys., 310(2):410-416, 1994.
Keller et al., "Insulin prophylaxis in individuals at high risk of type I diabetes," The Lancet, 341:927-928, Apr., 1993.
Knaack et al., "Clonal Insulinoma Cell Line That Stably Maintains Correct Glucose Responsiveness," Diabetes, 43:1413-1417, Dec., 1994.
Lee et al., ".beta.-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-.beta.-cell relationships," Proc. Natl. Acad. Sci. USA, 91:10878-10882, Nov., 1994.
McGarry and Foster, "Regulation of Hepatic Fatty Acid Oxidation and Ketone Body Production," Ann. Rev. Biochem., 49:395-420, 1980.
McGarry, "What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes," Science, 258:766-770, Oct., 1992.
Milburn et al., "Pancreatic .beta.-Cells in Obesity," J. Biol. Chem., 270(3):1295-1299, Jan., 1995.
Moore and Kelly, "Secretory protein targeting in a pituitary cell line: Differential transport of foreign secretory proteins to distinct secretory pathways," J. Cell Biol., 101:1773-1781, 1985.
Muir, et al., "Insulin Immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet and interferon-gamma transcription," J. Clin. Invest., 95(2);628-34, Feb., 1995.
Newgard et al., "Engineering of glucose-stimulated insulin release in clonal cells. Therapeutic implications," Diab. Nutr. Metab., 5(Suppl. 1):15-20, 1992.
Newgard et al., "Molecular engineering of glucose-regulated insulin secretion," In Molecular Biology of Diabetes, Draznin, B. and LeRoith, D. Eds. Humana Press Inc., Totowa, N.J., Part 1, Chap. 6:1191-54, 1994.
Newgard and McGarry, "Metabolic coupling factors in pancreatic Beta-cell signal transduction," Ann. Rev. Biochem., 64:689-719, 1995.
Newgard, "Perspectives in Diabetes: Cellular Engineering and Gene Therapy Strategies for Insulin Replacement in Diabetes," Diabetes, 43:341-350, Mar., 1994.
Newgard et al., "Molecular Engineering of the Pancreatic .beta.-Cell," J. Lab. Clin. Med., 122:356-363, 1993.
Ogawa et al., "Loss of glucose-induced secretion and GLUT2 expression in transplanted .beta.-cells," Diabetes, 44:75-79, Jan., 1995.
Polakis and Wilson, "An Intact Hydrophobic N-Terminal Sequence Is Critical for Binding of Rat Brain Hexokinase to Mitochondria," Arch. Biochem. Biophys., 236(1):328-337, Jan., 1985.
Randle et al., "Mechanisms Decreasing Glucose Oxidation in Diabetes and Starvation: Role of Lipid Fuels and Hormones," Diabetes, Metab. Rev., 4(7):623-638, 1988.
Sambanis et al., "Multiple episodes of induced secretion of human growth hormone from recombinant AtT-20 cells," Cytotechnology, 4:111-119, 1990.
Sambanis et al., "Use of regulated secretion in protein production from animal cells: An evaluation with the AtT-20 model cell line," Biotechnology and Bioengineering, 35:771-780, 1990.
Sambanis et al., "A model of secretory protein trafficking in recombinant AtT-20 cells," Biotechnology and Bioengineering, 36:280-295, 1991.
Schar
Board of Regents , The University of Texas System
Gucker Stephen
Hutzell Paula K.
LandOfFree
Methods for producing human insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for producing human insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for producing human insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1621131